PRINCETON, N.J., Nov. 21, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the introduction of Simcyp™ Biopharmaceutics software. It is designed ...
A new guideline for conducting bioequivalence studies was adopted by the CPMP in January and it becomes fully effective as of August 2010. A new guideline 1 for conducting bioequivalence studies was ...
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP), the leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals, and consumer goods ...
The Indian Pharmacopoeia Commission (IPC) has successfully participated and concluded World Health Organisation (WHO) Biowaiver Project for Biopharmaceutics Classification System (BCS) based ...
Funded collaborative research effort strengthens the population simulation functionality in GastroPlus® Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995 – With the ...
PRINCETON, N.J., Nov. 21, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the introduction of Simcyp Biopharmaceutics software. It is designed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback